|
|
|
|
Document Preview Agreement and Plan of Merger |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Agreement and Plan of Merger |
|||
|
Entities: |
||||
|
Date: |
2005 |
|||
|
Size: |
263KB total |
|||
|
Price: |
$76 |
|||
|
ID: |
#1115139 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
Exhibit 99.1
AGREEMENT AND PLAN OF MERGER
by and among
CLINICAL DATA, INC.,
SAFARI ACQUISITION CORPORATION
and
GENAISSANCE PHARMACEUTICALS, INC.
Dated as of June 20, 2005
TABLE OF CONTENTS
|
ARTICLE I |
THE MERGER |
|
|
|
|
|
|
1.1 |
Effective Time of the Merger |
|
|
|
|
|
|
1.2 |
Closing |
|
|
|
|
|
|
1.3 |
Amendment of Company Charter |
|
|
|
|
|
|
1.4 |
Amendment of Parent Charter |
|
|
|
|
|
|
1.5 |
Effects of the Merger |
|
|
|
|
|
|
ARTICLE II |
CONVERSION OF SECURITIES |
|
|
|
|
|
|
2.1 |
Conversion of Capital Stock |
|
|
|
|
|
|
2.2 |
Exchange of Certificates |
|
|
|
|
|
|
ARTICLE III |
REPRESENTATIONS AND WARRANTIES OF THE COMPANY |
|
|
|
|
|
|
3.1 |
Organization, Standing and Power; Subsidiaries |
|
|
|
|
|
|
3.2 |
Capitalization |
|
|
|
|
|
|
3.3 |
Authority; No Conflict; Required Filings and Consents |
|
|
|
|
|
|
3.4 |
SEC Filings; Financial Statements; Information Provided |
|
|
|
|
|
|
3.5 |
No Undisclosed Liabilities; Indebtedness |
|
|
|
|
|
|
3.6 |
Absence of Certain Changes or Events |
|
|
|
|
|
|
3.7 |
Taxes |
|
|
|
|
|
|
3.8 |
Owned and Leased Real Properties |
|
|
|
|
|
|
3.9 |
Intellectual Property |
|
|
|
|
|
|
3.10 |
Agreements, Contracts and Commitments; Government Contracts |
|
|
|
|
|
|
3.11 |
Litigation; Product Liability |
|
|
|
|
|
|
3.12 |
Environmental Matters |
|
|
|
|
|
|
3.13 |
Employee Benefit Plans |
|
|
|
|
|
|
3.14 |
Compliance With Laws |
|
|
|
|
|
|
3.15 |
Permits |
|
|
|
|
|
|
3.16 |
Labor Matters |
|
|
|
|
|
|
3.17 |
Insurance |
|
|
|
|
|
|
3.18 |
Assets |
|
|
|
|
|
|
3.19 |
Customers and Suppliers |
|
|
|
|
|
|
3.20 |
Opinion of Financial Advisor |
|
|
|
|
|
|
3.21 |
Section 203 of the DGCL Not Applicable |
|
i
|
3.22 |
Brokers; Schedule of Fees and Expenses |
|
|
|
|
|
|
ARTICLE IV |
REPRESENTATIONS AND WARRANTIES OF THE PARENT AND THE TRANSITORY SUBSIDIARY |
|
|
|
|
|
|
4.1 |
Organization, Standing and Power |
|
|
|
|
|
|
4.2 |
Capitalization |
|
|
|
|
|
|
4.3 |
Authority; No Conflict; Required Filings and Consents |
|
|
|
|
|
|
4.4 |
SEC Filings; Financial Statements; Information Provided |
|
|
|
|
|
|
4.5 |
Absence of Certain Changes or Events |
|
|
|
|
|
|
4.6 |
Intellectual Property |
|
|
|
|
|
|
4.7 |
Agreements, Contracts and Commitments |
|
|
|
|
|
|
4.8 |
Litigation; Product Liability |
|
|
|
|
|
|
4.9 |
Compliance With Laws |
|
|
|
|
|
|
4.10 |
Permits |
|
|
|
|
|
|
4.11 |
Operations of the Transitory Subsidiary |
|
|
|
|
|
|
4.12 |
Opinion of Financial Advisor |
|
|
|
|
|
|
4.13 |
Brokers; Schedule of Fees and Expenses |
|
|
|
|
|
|
ARTICLE V |
CONDUCT OF BUSINESS |
|
|
|
|
|
|
5.1 |
Covenants of the Company |
|
|
|
|
|
|
5.2 |
Confidentiality |
|
|
|
|
|
|
ARTICLE VI |
ADDITIONAL AGREEMENTS |
|
|
|
|
|
|
6.1 |
No Solicitation |
|
|
|
|
|
|
6.2 |
Joint Proxy Statement/Prospectus; Registration Statement |
|
|
|
|
|
|
6.3 |
Nasdaq Quotation |
|
|
|
|
|
|
6.4 |
Access to Information |
|
|
|
|
|
|
6.5 |
Stockholders Meetings |
|
|
|
|
|
|
6.6 |
Legal Conditions to the Merger |
|
|
|
|
|
|
6.7 |
Public Disclosure |
|
|
|
|
|
|
6.8 |
Section 368(a) Reorganization |
|
|
|
|
|
|
6.9 |
Affiliate Legends |
|
|
|
|
|
|
6.10 |
Nasdaq Stock Market Listing |
|
|
|
|
|
|
6.11 |
Company Stock Plans and Company Warrants |
|
|
|
|
|
|
6.12 |
Indemnification |
|
|
|
|
|
|
6.13 |
Notification of Certain Matters |
|
ii
|
6.14 |
Exemption from Liability Under Section 16(b) |
|
|
|
|
|
|
ARTICLE VII |
CONDITIONS TO MERGER |
|
|
|
|
|
|
7.1 |
Conditions to Each Partys Obligation To Effect the Merger |
|
|
|
|
|
|
7.2 |
Additional Conditions to Obligations of the Parent and the Transitory Subsidiary |
|
|
|
|
|
|
7.3 |
Additional Conditions to Obligations of the Company |
|
|
|
|
|
|
ARTICLE VIII |
TERMINATION AND AMENDMENT |
|
|
|
|
|
|
8.1 |
Termination |
|
|
|
|
|
|
8.2 |
Effect of Termination |
|
|
|
|
|
|
8.3 |
Fees and Expenses |
|
|
|
|
|
|
8.4 |
Amendment |
|
|
|
|
|
|
8.5 |
Extension; Waiver |
|
|
|
|
|
|
ARTICLE IX |
MISCELLANEOUS |
|
|
|
|
|
|
9.1 |
Nonsurvival of Representations and Warranties |
|
|
|
|
|
|
9.2 |
Notices |
|
|
|
|
|
|
9.3 |
Entire Agreement |